title: Disability and borderline personality symptoms.
authors.forename: Randy A
authors.initials: RA
authors.lastname: Sansone
authors.forename: Judith
authors.initials: J
authors.lastname: Hruschka
authors.forename: Archana
authors.initials: A
authors.lastname: Vasudevan
authors.forename: Stephanie N
authors.initials: SN
authors.lastname: Miller
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy; D015897:Comorbidity; D003865:Major Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D006945:Hyperhidrosis / Q000188:drug therapy*; D008297:Male; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D008875:Middle Aged; D000078785:Mirtazapine; D016896:Treatment Outcome
chemical_list: D000317:Adrenergic alpha-Antagonists; D000929:Antidepressive Agents, Tricyclic; D008803:Mianserin; D000078785:Mirtazapine